Recipharm | Investor relations

Investor relations

Find out more about our financial situation and outlook.

26 Jan 2021, 17:29 The share

Recipharm Annual report 2019

Read Recipharm's Annual Report 2019

FINANCIAL CALENDAR

2021.01.28

Preliminary report January–December 2020

Will be published at approximately 07:45 am CET.

2021.02.18

Full year report January – December 2020

Will be published at 07:45 am CET.

2021.04.20

Annual Report 2020

Recipharm publishes Annual Report 2020

2021.05.06

Interim report January – March 2021

Will be published at 07:45 am CET.

Financial reports

Recipharm AB publishes its interim report for the third quarter 2020

2020-11-05

Recipharm AB publishes its interim report for the second quarter 2020

2020-07-27

Recipharm AB publishes its interim report January-March 2020

2020-05-07

See all financial reports

Financial press releases

Recipharm has convened a bondholder meeting to correct the terms and conditions of its convertible bonds and announces date for a preliminary 2020 year-end report

2021-01-11

Announcement of consent solicitation by Recipharm AB (publ) in respect of its SEK 1,000,000,000 Senior Unsecured Convertible Bonds due 2021 (ISIN: XS1496895753)

2021-01-11

Recipharm and Moderna finalize agreement for aseptic drug product manufacturing and fill-finish for supply to countries outside the U.S.

2020-12-30

See all financial press releases

2020.11.05

Q3 report summary

Interim report - Q3 2020

Read the whole report here

Listen to the webcast presentation here

Q3 report 2020 presentation

2020.07.27

Q2 report summary

Interim report - Q2 2020

Read the whole report here

Listen to the webcast presentation here

Q2 report 2020 presentation

2020.05.07

Q1 report summary

Interim report January - March 2020

Read the whole report here

Listen to the webcast presentation here

Q1 report 2020 presentation

2020.02.20

Q4 report summary

Full year report 2019

Read the whole report here

Listen to the webcast presentation here

Q4 report 2019 presentation

Mandatory public offer

On 14 December 2020, EQT IX, through Roar BidCo AB, announced a public offer to the shareholders of Recipharm AB (publ).
Information about the offer and timeline may be found on the offeror's web site.

Contact

Contact details

ir@recipharm.com

+46 8 602 52 00